Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|December 2, 2011
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinomaJustin M Julius, Anjali Gaikwad, Amy Lowry, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2017
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolatesPaolo Gaibani, Russell E Lewis, Silvia L Volpe, et al.
Journal of Fungi (Basel, Switzerland)|April 3, 2021
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic CancerDierdre B Axell-House, Sebastian Wurster, Ying Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
Future directions in mucormycosis researchDimitrios P Kontoyiannis, Russell E Lewis, Oliver Lortholary, et al.
Journal of Hepatology|April 1, 2014
Epidemiology and outcomes of bloodstream infection in patients with cirrhosisMichele Bartoletti, Maddalena Giannella, Paolo Caraceni, et al.
Medicine|November 15, 2014
Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapyNicolò Girometti, Russell E Lewis, Maddalena Giannella, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosisSebastian Wurster, Jezreel Pantaleon Garcia, Yongxing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2026
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosisSebastian Wurster, Jezreel Pantaleon Garcia, Yongxing Wang, et al.
The Journal of Infectious Diseases|March 7, 2006
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida speciesGeorgios Chamilos, Michail S Lionakis, Russell E Lewis, et al.
Haematologica|June 8, 2006
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)Georgios Chamilos, Mario Luna, Russell E Lewis, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|December 2, 2011
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinomaJustin M Julius, Anjali Gaikwad, Amy Lowry, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2017
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolatesPaolo Gaibani, Russell E Lewis, Silvia L Volpe, et al.
Journal of Fungi (Basel, Switzerland)|April 3, 2021
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic CancerDierdre B Axell-House, Sebastian Wurster, Ying Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
Future directions in mucormycosis researchDimitrios P Kontoyiannis, Russell E Lewis, Oliver Lortholary, et al.
Journal of Hepatology|April 1, 2014
Epidemiology and outcomes of bloodstream infection in patients with cirrhosisMichele Bartoletti, Maddalena Giannella, Paolo Caraceni, et al.
Medicine|November 15, 2014
Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapyNicolò Girometti, Russell E Lewis, Maddalena Giannella, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosisSebastian Wurster, Jezreel Pantaleon Garcia, Yongxing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2026
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosisSebastian Wurster, Jezreel Pantaleon Garcia, Yongxing Wang, et al.
The Journal of Infectious Diseases|March 7, 2006
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida speciesGeorgios Chamilos, Michail S Lionakis, Russell E Lewis, et al.
Haematologica|June 8, 2006
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)Georgios Chamilos, Mario Luna, Russell E Lewis, et al.
Pageof 21